Cardinal Health's Pharma Segment CEO Sells Shares but Increases Overall Stake
Deborah Weitzman, the CEO of Cardinal Health’s Pharmaceutical and Specialty Solutions segment, sold 7,354 shares in a recent SEC Form 4 filing. Despite this sale, her direct stake increased by approximately 47% due to performance-based share awards received earlier that month. The transaction reduced her holdings by about 9%, but she still holds over 77,000 shares valued at around $18.3 million as of August 18. The sale occurred at a weighted average price of $235.45 per share, with individual prices ranging from $235.17 to $237.63. Cardinal Health remains one of the largest healthcare services companies globally, reporting trailing twelve-month revenue of $254.2 billion and a market capitalization of $55.0 billion as of August 19.
Tickers: $CAH
Topics: Cardinal Health executive sale SEC filing